HUP0301944A2 - Alkoholizmus kialakulása kockázatának diagnosztizálása személyekben - Google Patents

Alkoholizmus kialakulása kockázatának diagnosztizálása személyekben

Info

Publication number
HUP0301944A2
HUP0301944A2 HU0301944A HUP0301944A HUP0301944A2 HU P0301944 A2 HUP0301944 A2 HU P0301944A2 HU 0301944 A HU0301944 A HU 0301944A HU P0301944 A HUP0301944 A HU P0301944A HU P0301944 A2 HUP0301944 A2 HU P0301944A2
Authority
HU
Hungary
Prior art keywords
alcoholism
person
subject
diagnosis
development
Prior art date
Application number
HU0301944A
Other languages
English (en)
Inventor
Matti Karvonen
Jussi Kauhanen
Markku Koulu
Ullamari Pesonen
Matti Uusitupa
Original Assignee
Hormos Medical Oy Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Oy Ltd. filed Critical Hormos Medical Oy Ltd.
Publication of HUP0301944A2 publication Critical patent/HUP0301944A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57545Neuropeptide Y
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Addiction (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A találmány tárgyát személyek alkoholizmus kialakulása kockázatávalszembeni fogékonyságának diagnosztizálására alkalmas eljárásokképezik. A találmány tárgyát képezik továbbá az alkoholizmuskialakulásával szemben fokozott fogékonyságúnak diagnosztizáltszemélyek kezelésére szolgáló, az említett állapot kialakulásánakmegelőzését célzó eljárások is. A találmány tárgyát képezik emellettaz alkoholizmus megelőzésében vagy kezelésében eredményesenalkalmazható gyógyhatású anyagok vagy genetikai célmolekulákvizsgálatára vagy szkrínelésére alkalmas, transzgénikus állatotmagában foglaló állati modellt alkalmazó eljárások is. Ó
HU0301944A 2000-03-21 2001-02-06 Alkoholizmus kialakulása kockázatának diagnosztizálása személyekben HUP0301944A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21932400P 2000-03-21 2000-03-21
PCT/FI2001/000103 WO2001071029A1 (en) 2000-03-21 2001-02-06 Diagnosis of a person's risk of developing alcoholism

Publications (1)

Publication Number Publication Date
HUP0301944A2 true HUP0301944A2 (hu) 2003-09-29

Family

ID=22818825

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301944A HUP0301944A2 (hu) 2000-03-21 2001-02-06 Alkoholizmus kialakulása kockázatának diagnosztizálása személyekben

Country Status (16)

Country Link
US (1) US20030224362A1 (hu)
EP (1) EP1266029A1 (hu)
JP (1) JP2003527865A (hu)
AU (1) AU3381801A (hu)
BG (1) BG106583A (hu)
BR (1) BR0107845A (hu)
CA (1) CA2383848A1 (hu)
CZ (1) CZ20022469A3 (hu)
EE (1) EE200200416A (hu)
HU (1) HUP0301944A2 (hu)
NO (1) NO20021378D0 (hu)
NZ (1) NZ517908A (hu)
PL (1) PL362862A1 (hu)
SK (1) SK4212002A3 (hu)
WO (1) WO2001071029A1 (hu)
ZA (1) ZA200201868B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0807421D0 (en) * 2008-04-23 2008-05-28 Ucl Business Plc Markers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046317A (en) * 1997-12-19 2000-04-04 Hormos Medical Oy, Ltd. DNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof
US6312898B1 (en) * 1999-04-15 2001-11-06 Hormos Medical Oy, Ltd. Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene

Also Published As

Publication number Publication date
PL362862A1 (en) 2004-11-02
BG106583A (en) 2003-04-30
EP1266029A1 (en) 2002-12-18
JP2003527865A (ja) 2003-09-24
SK4212002A3 (en) 2002-11-06
CZ20022469A3 (cs) 2002-10-16
BR0107845A (pt) 2002-10-22
CA2383848A1 (en) 2001-09-27
US20030224362A1 (en) 2003-12-04
WO2001071029A1 (en) 2001-09-27
EE200200416A (et) 2003-12-15
NZ517908A (en) 2003-07-25
NO20021378L (no) 2002-03-20
NO20021378D0 (no) 2002-03-20
AU3381801A (en) 2001-10-03
ZA200201868B (en) 2003-03-06

Similar Documents

Publication Publication Date Title
Westman et al. Noise and stress: a comprehensive approach.
DE60314236D1 (de) Verfahren zur diagnose und therapie von schizophrenie
DE69942614D1 (de) Vorrichtung zur diagnose und therapie von elektrophysiologischen krankheiten
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
IL154794A0 (en) Remedies for heart failure
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
ATE415632T1 (de) Verfahren zur diagnose und behandlung von morbus crohn
EE200100533A (et) Ateroskleroosi või diabeetilise retionopaatia arenemise riski diagnoosimine isikutel
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
GB2431348A (en) Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
HUP0301944A2 (hu) Alkoholizmus kialakulása kockázatának diagnosztizálása személyekben
Babamiri et al. The Role of individual susceptibility to the effects of low frequency noise on cognitive Performances
DE60127935D1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
DE60033646D1 (de) Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheit
RU2311691C2 (ru) Способ моделирования деперсонализационного расстройства
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
DE60225845D1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
WO2004019875A3 (en) Non-invasive methods to identify agents for treating pain
Almira et al. Identification behavior changes of mice (Mus musculus) as effect of noise exposure
RU2163020C1 (ru) Способ диагностики токсического хронического панкреатита у лиц, работающих в контакте с хлорорганическими пестицидами
FR2846658B1 (fr) Peptides pour la prevention, le diagnostic et le traitement de la leptospirose animale et/ou humaine.
ATE323287T1 (de) Verfahren zur diagnose und behandlung von huntingtonserkrankung
Ghahraman et al. ÔØ Å ÒÙ× Ö ÔØ
GB2382579B (en) Disease models, assays, methods and means